Cell Salts NDC 55714-4831

NDC codes

FDA NDC Directory

Product NDC (as listed)55714-4831Labeler and product segments. Claims need a package NDC.

Product NDC at billing width55714-4831Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
55714-4831-1	55714483101	30 mL in 1 BOTTLE, GLASS (55714-4831-1)Marketed from Sep 2, 2019

How the 11-digit form is made: The package segment has 1 digit, so one leading zero is added to it (5-4-1 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cell Salts
Generic name (nonproprietary): calc. fluor., calc. phos., calc.sulph., ferrum phosphoricum, kali mur., kali phos., kali sulph., mag. phos., nat. mur., nat. phos., nat.sulphuricum, silicea
Active ingredients: Calcium fluoride — 15 [hp_X]/mLTribasic calcium phosphate — 15 [hp_X]/mLCalcium sulfate anhydrous — 15 [hp_X]/mLFerrosoferric phosphate — 15 [hp_X]/mLPotassium chloride — 15 [hp_X]/mLDibasic potassium phosphate — 15 [hp_X]/mLPotassium sulfate — 15 [hp_X]/mLMagnesium phosphate, Dibasic trihydrate — 15 [hp_X]/mLSodium chloride — 15 [hp_X]/mLSodium phosphate, Dibasic, Heptahydrate — 15 [hp_X]/mLSodium sulfate — 15 [hp_X]/mLSilicon dioxide — 15 [hp_X]/mL
Dosage form: Liquid
Route: Oral
Labeler: Newton Laboratories, Inc.
Product type: Over-the-counter drug
Marketing category: Unapproved homeopathic
Marketing start: Sep 2, 2019
Listing expires: Dec 31, 2026
Other FDA classes: Calcium (Chemical structure)Divalent (Chemical structure)Increased Coagulation Factor Activity (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Increased Large Intestinal Motility (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Large Intestine Fluid/Electrolyte Absorption (Physiologic effect)Inhibition Small Intestine Fluid/Electrolyte Absorption (Physiologic effect)Magnesium Ion Exchange Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Osmotic Activity (Mechanism)Phosphate Chelating Activity (Mechanism)Potassium Compounds (Chemical structure)Stimulation Large Intestine Fluid/Electrolyte Secretion (Physiologic effect)
Identifiers: Product ID 55714-4831_3ac4207f-1085-5311-e063-6294a90aca42SPL ID 3ac4207f-1085-5311-e063-6294a90aca42SPL set ID 985a3341-0fe0-1dd6-e053-2a95a90ad2c5UNII O3B55K4YKI, 91D9GV0Z28, E934B3V59H, 91GQH8I5F7, 660YQ98I10, CI71S98N1Z, 1K573LC5TV, HF539G9L3Q, 451W47IQ8X, 70WT22SF4B, 0YPR65R21J, ETJ7Z6XBU4
Pharmacologic class: Blood Coagulation Factor; Calculi Dissolution Agent; Osmotic Laxative; Phosphate Binder; Potassium Salt

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N455714483101 followed by a unit qualifier and the quantity

Package 55714-4831-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jul 25, 2025.

Indications (excerpt from the label)

INDICATIONS & USAGE SECTION A formulation of the 12 tissue salts for symptoms such as indigestion, exhaustion, inflammation and sensitive skin.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)